{
    "clinical_study": {
        "@rank": "159787", 
        "arm_group": [
            {
                "arm_group_label": "Berocca Boost", 
                "arm_group_type": "Active Comparator", 
                "description": "Guarana and vitamin and mineral complex, one tablet dissolved in 250ml water taken once."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Matched placebo tablet, one tablet dissolved in 250ml water taken once."
            }
        ], 
        "brief_summary": {
            "textblock": "Consuming a guaran\u00e1 and vitamin and mineral complex can improve mental fatigue and cognitive\n      function at rest; guaran\u00e1 also contains caffeine, which can reduce perceived exertion and\n      increase fat burning during exercise. The purpose of this study is to test whether consuming\n      a guaran\u00e1 and vitamin and mineral product before exercise influences affect (mood), physical\n      exertion and fat burning during exercise and mental fatigue, cognitive performance and\n      affect post-exercise."
        }, 
        "brief_title": "The Effect of Consuming a Guaran\u00e1 and Vitamin and Mineral Complex Before Exercise on Affect, Exertion, Substrate Metabolism and Cognitive Performance", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Affect and Exertion During and Post-exercise", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Individuals must be:\n\n          -  Healthy\n\n          -  Male\n\n          -  Aged between 18 and 35years\n\n          -  Habitually active (exercising at least twice a week)\n\n          -  Able to run at a moderate pace for 30 minutes non-stop on a treadmill\n\n        Exclusion Criteria:\n\n        Individuals will not be eligible to take part in this study if they:\n\n          -  have a history of neurological or psychiatric diseases excluding anxiety or\n             depression\n\n          -  have a current diagnosis of depression or anxiety\n\n          -  have a history of significant head trauma, metabolic, endocrine or cardiac disorders\n\n          -  have smoked within the last 3 months,\n\n          -  have high blood pressure >140/90mmHg\n\n          -  consume > 500 mg caffeine per day from all dietary sources\n\n          -  have adverse reactions to caffeine containing products (i.e. tea, coffee, energy\n             drinks, cola, Pepsi)\n\n          -  are currently taking any pharmaceuticals\n\n          -  have habitual taken dietary supplements within the last 4 weeks (defined as \u22653\n             consecutive days or \u22654 days in total per week)\n\n          -  have current or history of drug or alcohol abuse\n\n          -  have participated in another clinical trial within 30 days prior to screening\n\n          -  have any condition which may interfere with your ability to perform assessments\n\n          -  have any history of hypersensitivity to the investigational product or its active or\n             inactive constituents or any food allergy or intolerance"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01929694", 
            "org_study_id": "9B2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Berocca Boost", 
                "intervention_name": "Berocca Boost", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Vitamins"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Newcastle upon Tyne", 
                    "country": "United Kingdom", 
                    "state": "Tyne and Wear", 
                    "zip": "NE18ST"
                }, 
                "name": "Brain, Performance and Nutrition Research Centre, Northumbria Univerity"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Consuming a Guaran\u00e1 and Vitamin and Mineral Complex Before a Morning Exercise Session on Affect, Exertion and Substrate Metabolism During Exercise and Cognitive Performance During the Post-exercise Recovery Period", 
        "other_outcome": [
            {
                "description": "Participants will complete a set of cognitive tasks (Immediate Word Recall, Choice Reaction Time, Rapid visual information processing task, Numeric Working Memory, Delayed word Recall, Word Recognition and Picture Recognition) measuring episodic memory, working memory, attention and decision making.", 
                "measure": "Cognitive Function", 
                "safety_issue": "No", 
                "time_frame": "Assessed at baseline, pre-exercise and immeadiately and 75min post-exercise"
            }, 
            {
                "description": "Assessed using the Bond-Lader Visual Analogue Scales (VAS) and Energy VAS (concentration, physical stamina, mental stamina)", 
                "measure": "Mood", 
                "safety_issue": "No", 
                "time_frame": "Assessed at baseline, pre-exercise and immeadiately and 75min post-exercise"
            }, 
            {
                "description": "Measured using an online gas analysis system (Cortex). Oxygen uptake, carbon dioxide production, fat and carbohydrate oxidation and energy expenditure will be measured for 1 min at each 10min interval.", 
                "measure": "Substrate Metabolism", 
                "safety_issue": "No", 
                "time_frame": "Measured at 10min intervals during exercise"
            }
        ], 
        "overall_official": {
            "affiliation": "Northumbria University", 
            "last_name": "Rachel Veasey, MSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Brain, Performance and Nutrition Research Centre, Northumbria University", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Affect measured using the Feeling Scale and Felt Arousal Scale", 
            "measure": "Affect", 
            "safety_issue": "No", 
            "time_frame": "Assessed pre-exercise, at 10min intervals during exercise and 45 and 75min post-exercise"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01929694"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Rate of perceived exertion measured using the Borg scale", 
            "measure": "Exertion", 
            "safety_issue": "No", 
            "time_frame": "Measured at 10min intervals during exercise"
        }, 
        "source": "Northumbria University", 
        "sponsors": {
            "collaborator": {
                "agency": "Bayer", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Northumbria University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}